If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 55 Similar Profiles
Natural Killer Cells Medicine & Life Sciences
Fetal Blood Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences
Transplantation Medicine & Life Sciences
Transplants Medicine & Life Sciences
KIR Receptors Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1996 2022

Epithelial Cell Adhesion Molecule
myeloid leukemia
natural killer cells
Natural Killer Cell Receptors
Transplantation
Neoplasms
Therapeutics
Sarcoma
Immune System
Pediatrics
scorpion toxin I''

Research Output 1991 2018

Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect

Rashidi, A., Ebadi, M., Said, B., Cao, Q., Shanley, R., Curtsinger, J., Bejanyan, N., Warlick, E. D., Green, J. S., Brunstein, C. G., Miller, J. S. & Weisdorf, D. J., Aug 1 2018, In : American Journal of Hematology. 93, 8, p. 1014-1019 6 p.

Research output: Contribution to journalArticle

Fetal Blood
Allografts
Viruses
Transplants
Neoplasms

Adaptive NK cells resist regulatory T-cell suppression driven by IL37

Sarhan, D., Hippen, K. L., Lemire, A., Hying, S., Luo, X., Lenvik, T., Curtsinger, J., Davis, Z., Zhang, B., Cooley, S., Cichocki, F., Blazar, B. R. & Miller, J. S., Jul 1 2018, In : Cancer immunology research. 6, 7, p. 766-775 10 p.

Research output: Contribution to journalArticle

Regulatory T-Lymphocytes
Natural Killer Cells
Natural Killer Cell Receptors
Tumor Microenvironment
Programmed Cell Death 1 Receptor
3 Citations

A first-in-human phase I study of subcutaneous outpatient recombinant human IL15 (rhIL15) in adults with advanced solid tumors

Miller, J. S., Morishima, C., McNeel, D. G., Patel, M. R., Kohrt, H. E. K., Thompson, J. A., Sondel, P. M., Wakelee, H. A., Disis, M. L., Kaiser, J. C., Cheever, M. A., Streicher, H., Creekmore, S. P., Waldmann, T. A. & Conlon, K. C., Apr 1 2018, In : Clinical Cancer Research. 24, 7, p. 1525-1535 11 p.

Research output: Contribution to journalArticle

Interleukin-15
Outpatients
Neoplasms
Natural Killer Cells
Troponin
4 Citations

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

Wrangle, J. M. , Velcheti, V. , Patel, M. R. , Garrett-Mayer, E. , Hill, E. G. , Ravenel, J. G. , Miller, J. S. , Farhad, M. , Anderton, K. , Lindsey, K. , Taffaro-Neskey, M. , Sherman, C. , Suriano, S. , Swiderska-Syn, M. , Sion, A. , Harris, J. , Edwards, A. R. , Rytlewski, J. A. , Sanders, C. M. , Yusko, E. C. & 9 others Robinson, M. D., Krieg, C., Redmond, W. L., Egan, J. O., Rhode, P. R., Jeng, E. K., Rock, A. D., Wong, H. C. & Rubinstein, M. P., May 1 2018, In : The Lancet Oncology. 19, 5, p. 694-704 11 p.

Research output: Contribution to journalArticle

Interleukin-15
Non-Small Cell Lung Carcinoma
Immunotherapy
ALT-803
nivolumab
2 Citations

ALT-803 transiently reduces simian immunodeficiency virus replication in the absence of antiretroviral treatment

Ellis-Connell, A. L., Balgeman, A. J., Zarbock, K. R., Barry, G., Weiler, A., Egan, J. O., Jeng, E. K., Friedrich, T., Miller, J. S., Haase, A. T., Schacker, T. W., Wong, H. C., Rakasz, E. & O'Connor, S. L., Feb 1 2018, In : Journal of Virology. 92, 3, e01748-17

Research output: Contribution to journalArticle

Simian immunodeficiency virus
Simian Immunodeficiency Virus
Virus Replication
virus replication
T-lymphocytes